Witryna14 sty 2024 · Consulting firm IMS Health believes the Asian pharmaceutical market outperforms all others. The per capita expenditure on health increased from 61 USD in 2008 to 108 USD in 2012 at the average annual exchange rate, but it stays below the Philippines ($ 119), Thailand ($ 215), and well below Malaysia ($ 410). Witryna19 sie 2024 · Market research firm IBM said that the size of Vietnam's pharmaceutical industry may reach USD 7.7 billion in 2024 and USD 16.1 billion in 2026. Market research firm IMS Health also forecasts that per capita spending on pharmaceuticals in Vietnam will rise to USD 50 per person in 2024.
IMS HEALTH SP Z O O (KRS: 0000013006, NIP: 5260152689, …
Witrynaworld's number one supplier of information to the pharmaceutical and healthcare industry. IMS HEALTH describes itself as "the world’s leading provider of information solutions to the pharmaceutical and healthcare industries". IMS is active in 100 countries. IMS' turnover was USD 1.4 billion in 2000 with an increase of 1.9% … WitrynaIMS Health GmbH & Co. OHG v NDC Health GmbH & Co. KG. Reference for a preliminary ruling: Landgericht Frankfurt am Main - Germany. Competition - Article 82 EC - Abuse of a dominant position - Brick structure used to supply regional sales data for pharmaceutical products in a Member State - Copyright - Refusal to grant a licence. … simplicity\u0027s fh
IMS Health : Login
WitrynaIMS Health Vietnam Jan 2016- Present7 years 3 months Ho Chi Minh City Associate Research Director TNS Vietnam Aug 2013- Jul 20152 … Witryna19 sie 2024 · Market research firm IBM said that the size of Vietnam's pharmaceutical industry may reach USD 7.7 billion in 2024 and USD 16.1 billion in 2026. Market … WitrynaIQVIA Vietnam provides biopharmaceutical and other healthcare clients with a full range of services and solutions to improve their probability of success. We understand … About IQVIA Vietnam We have been operating in Vietnam for more than a … simplicity\\u0027s fd